<DOC>
	<DOCNO>NCT02848339</DOCNO>
	<brief_summary>Data aspirin desensitization patient coronary artery disease undergo percutaneous coronary intervention sparse . This prospective , multicenter , observational study include 7 italian center , assess safety feasibility standard desensitization protocol patient aspirin sensitivity undergo coronary angiography . Patients history aspirin sensitivity undergo coronary angiography prospectively enrolled.All patient underwent desensitization procedure six sequential dos aspirin ( 1 , 5 , 10 , 20 , 40 , 100 mg ) administer orally predefined interval , procedure last 5.5 hours.All patient follow desensitization procedure success , description reaction due desensitization procedure , hospital major adverse cardiac event ( MACE ) . All patient also followed-up 12 month order ass long-term risk MACE , compliance ASA therapy , late occurrence side reaction due ASA sensitivity .</brief_summary>
	<brief_title>Aspirin Desensitization Registry Patients With Aspirin Hypersensitivity</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>history aspirin hypersensitivity acute coronary syndrome known/suspected stable coronary artery disease intent undergo percutaneous coronary intervention withdrawal consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>